EntryPoint Capital, LLC
- SEC CIK
- 0001992519
- Latest filing
- Aug 13, 2026
AMRX holding history
Amneal Pharmaceuticals, Inc. in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −60,573−100.0% | Sold out | Holders |
| Q2 2025 | 60,573 | $490.0K | 0.2% | +10,043+19.9% | Added | Holders |
| Q1 2025 | 50,530 | $423.4K | 0.2% | +50,530 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −12,725−100.0% | Sold out | Holders |
| Q3 2024 | 12,725 | $105.9K | 0.1% | −5,286−29.3% | Reduced | Holders |
| Q2 2024 | 18,011 | $114.4K | 0.1% | +18,011 | New | Holders |